Primær perkutan koronarintervention ved akut myokardieinfarkt: En sammenligning med DANAMI 2-resultater

Samir M. Ali Aljabbari, Jan Kyst Madsen*, Henning Kelbæk, Steffen Helqvist, Jens Flensted Lassen, Erik Jørgensen, Kari Saunamäki

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    Introduction: Several studies, including the DANAMI-2 trial, have shown that primary percutanous intervention (PCI) results in better survival, fewer reinfarctions and fewer cerebrovascular incidents than thrombolysis in the treatment of acute ST-elevation myocardial infarction (STEMI). The aim of this study was to follow the implementation of primary PCI as a routine treatment for patients with STEMI and to compare the results with those of DANAMI-2. Materials and methods: We performed a prospective analysis of 212 patients admitted to our department from 1 April 2002 to 31 December 2002 with STEMI. Acute coronary angiography and, if indicated, primary PCI were performed. Results: At 30 days, the mortality rate was 6.6%, the reinfarction rate 1.4% and the rate of disabling stroke 1.4%. Combined endpoints were present in 8% of the patients. The results are in agreement with those from the DANAMI-2 trial. Dicussion: Primary PCI can be performed in daily clinical practice in accordance with the DANAMI-2 protocol. The results are in agreement with data from newly published meta-analyses.

    Bidragets oversatte titelPrimary percutanous intervention as a treatment of acute mycardial infarction: A comparison with the DANAMI-2 results
    Sider (fra-til)3036-3039
    Antal sider4
    TidsskriftUgeskrift for laeger
    Udgave nummer33
    StatusUdgivet - 15 aug. 2005


    Udforsk hvilke forskningsemner 'Primær perkutan koronarintervention ved akut myokardieinfarkt: En sammenligning med DANAMI 2-resultater' indeholder.